152 related articles for article (PubMed ID: 29382922)
1. ARHGEF39 promotes tumor progression via activation of Rac1/P38 MAPK/ATF2 signaling and predicts poor prognosis in non-small cell lung cancer patients.
Zhou H; Cai L; Zhang X; Li A; Miao Y; Li Q; Qiu X; Wang E
Lab Invest; 2018 May; 98(5):670-681. PubMed ID: 29382922
[TBL] [Abstract][Full Text] [Related]
2. FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma.
Cooke M; Kreider-Letterman G; Baker MJ; Zhang S; Sullivan NT; Eruslanov E; Abba MC; Goicoechea SM; García-Mata R; Kazanietz MG
Cell Rep; 2021 Nov; 37(5):109905. PubMed ID: 34731623
[TBL] [Abstract][Full Text] [Related]
3. ANKRD49 promotes the metastasis of NSCLC via activating JNK-ATF2/c-Jun-MMP-2/9 axis.
Sun J; Hu JR; Liu CF; Li Y; Wang W; Fu R; Guo M; Wang HL; Pang M
BMC Cancer; 2023 Nov; 23(1):1108. PubMed ID: 37964204
[TBL] [Abstract][Full Text] [Related]
4. ARHGEF39 promotes gastric cancer cell proliferation and migration via Akt signaling pathway.
Wang H; Li M; Tao X; Qian Y; Chen L; Tao G
Mol Cell Biochem; 2018 Mar; 440(1-2):33-42. PubMed ID: 28871449
[TBL] [Abstract][Full Text] [Related]
5. Noxin promotes proliferation of breast cancer cells via P38-ATF2 signaling pathway.
Zhang X; Zhang Y; Fan C; Wang L; Liu Y; Li A; Jiang G; Zhou H; Cai L; Miao Y
Tumour Biol; 2017 Jun; 39(6):1010428317705515. PubMed ID: 28618963
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of KLHL17 promotes the proliferation and migration of non-small cell lung cancer by activating the Ras/MAPK signaling pathway.
Liu Z; Zhao M; Jiang X; Zhang Y; Zhang S; Xu Y; Ren H; Su H; Wang H; Qiu X
Lab Invest; 2022 Dec; 102(12):1389-1399. PubMed ID: 35978057
[TBL] [Abstract][Full Text] [Related]
7. 6'-O-galloylpaeoniflorin regulates proliferation and metastasis of non-small cell lung cancer through AMPK/miR-299-5p/ATF2 axis.
Gao J; Song L; Xia H; Peng L; Wen Z
Respir Res; 2020 Feb; 21(1):39. PubMed ID: 32014006
[TBL] [Abstract][Full Text] [Related]
8. ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.
Zhang X; Zhou H; Zhang Y; Cai L; Jiang G; Li A; Miao Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Jun; 8(24):38863-38875. PubMed ID: 28418919
[TBL] [Abstract][Full Text] [Related]
9. IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer.
Wu Z; He D; Zhao S; Wang H
Mol Cell Biochem; 2019 May; 455(1-2):195-206. PubMed ID: 30564960
[TBL] [Abstract][Full Text] [Related]
10. ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer.
Li Y; Ye Z; Chen S; Pan Z; Zhou Q; Li YZ; Shuai WD; Kuang CM; Peng QH; Shi W; Mao X; Liu RY; Huang W
Int J Cancer; 2018 Apr; 142(7):1379-1391. PubMed ID: 29164615
[TBL] [Abstract][Full Text] [Related]
11. Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer.
Dong Q; Fu L; Zhao Y; Du Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Apr; 8(17):27800-27811. PubMed ID: 28468127
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
13. Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway.
Pan L; Tan Y; Wang B; Qiu W; Yin Y; Ge H; Zhu H
Cancer Res Treat; 2020 Jul; 52(3):867-885. PubMed ID: 32164050
[TBL] [Abstract][Full Text] [Related]
14. Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma.
Gao J; Jia WD
Med Sci Monit; 2019 Oct; 25():7826-7835. PubMed ID: 31626606
[TBL] [Abstract][Full Text] [Related]
15. TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.
Zhang X; Han S; Zhou H; Cai L; Li J; Liu N; Liu Y; Wang L; Fan C; Li A; Miao Y
Mol Carcinog; 2019 May; 58(5):767-776. PubMed ID: 30604908
[TBL] [Abstract][Full Text] [Related]
16. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
17. ARHGEF40 promotes non-small cell lung cancer proliferation and invasion via the AKT-Wnt axis by binding to RhoA.
Gu J; Zhang X; Jiang G; Li Q; Wang E; Yu J
Mol Carcinog; 2022 Nov; 61(11):1016-1030. PubMed ID: 36000254
[TBL] [Abstract][Full Text] [Related]
18. Induction of G2/M Cell Cycle Arrest via p38/p21
Pai JT; Hsu MW; Leu YL; Chang KT; Weng MS
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500594
[TBL] [Abstract][Full Text] [Related]
19. Silencing Ras-Related C3 Botulinum Toxin Substrate 1 Inhibits Growth and Migration of Hypopharyngeal Squamous Cell Carcinoma via the P38 Mitogen-Activated Protein Kinase Signaling Pathway.
Cheng H; Wang W; Wang G; Wang A; Du L; Lou W
Med Sci Monit; 2018 Feb; 24():768-781. PubMed ID: 29410394
[TBL] [Abstract][Full Text] [Related]
20. BCAR1 protein plays important roles in carcinogenesis and predicts poor prognosis in non-small-cell lung cancer.
Huang W; Deng B; Wang RW; Tan QY; He Y; Jiang YG; Zhou JH
PLoS One; 2012; 7(4):e36124. PubMed ID: 22558353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
